CAS：866021 - 48 - 9 Ceftaroline;

Ceftaroline Fosamil Acetate Hydrate;

Ceftaroline Impurity8;

7R)-2-Carboxy-7-[[(2Z)-(ethoxyimino)[5-(phosphonoamino)-1

Ceftarolin Fosamil

Unii-p9vxv1408y USP/EP/BP;

Ceftaroline USP/EP/BP;

acetic acid,(6R,7R)-7-[[(2Z)-2-ethoxyimino-2-[5-(phosphonoamino);

4-thiadiazol-3-yl]acetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-3-yl]thio]-4-thiazolyl]-1-methylpyridinium acetate hydrate;

Acute Bacterial Skin and Skin Structure Infections (ABSSSI): This product is indicated for ABSSSI caused by susceptible isolates of Staphylococcus aureus (including methicillin - resistant and methicillin - sensitive isolates), Streptococcus pyogenes, Streptococcus agalactiae, Escherichia coli, Klebsiella pneumoniae, and Klebsiella oxytoca, both Gram - positive and Gram - negative bacteria.

Community - acquired Bacterial Pneumonia (CABP): This product is indicated for CABP caused by susceptible isolates of Streptococcus pneumoniae (including bacteremia - associated cases), Staphylococcus aureus (methicillin - sensitive isolates), Haemophilus influenzae, Klebsiella pneumoniae, and Escherichia coli, both Gram - positive and Gram - negative bacteria.